David Brumbaugh
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medical Marijuana | 2 | 2021 | 107 | 1.230 |
Why?
| Foreign Bodies | 5 | 2020 | 103 | 1.070 |
Why?
| Esophagus | 4 | 2018 | 248 | 0.860 |
Why?
| Advisory Committees | 2 | 2020 | 219 | 0.780 |
Why?
| Clostridium Infections | 2 | 2023 | 56 | 0.750 |
Why?
| Fatty Liver | 2 | 2013 | 232 | 0.710 |
Why?
| Muscular Dystrophy, Duchenne | 2 | 2018 | 94 | 0.700 |
Why?
| Organizational Policy | 1 | 2020 | 76 | 0.670 |
Why?
| Specialties, Surgical | 1 | 2020 | 78 | 0.650 |
Why?
| Esophagoscopy | 2 | 2018 | 195 | 0.640 |
Why?
| Fecal Microbiota Transplantation | 2 | 2023 | 18 | 0.630 |
Why?
| Nutrition Disorders | 1 | 2018 | 24 | 0.620 |
Why?
| Electric Power Supplies | 4 | 2020 | 49 | 0.610 |
Why?
| Dilatation | 1 | 2018 | 59 | 0.600 |
Why?
| Esophageal Stenosis | 1 | 2018 | 51 | 0.600 |
Why?
| Fluoroscopy | 1 | 2018 | 155 | 0.590 |
Why?
| Epidermolysis Bullosa | 1 | 2018 | 59 | 0.590 |
Why?
| Hospitals, Pediatric | 2 | 2021 | 516 | 0.570 |
Why?
| Feces | 2 | 2017 | 432 | 0.550 |
Why?
| Diarrhea | 1 | 2017 | 177 | 0.540 |
Why?
| Gastrointestinal Diseases | 1 | 2018 | 197 | 0.530 |
Why?
| Surgeons | 1 | 2020 | 274 | 0.520 |
Why?
| Pharynx | 1 | 2016 | 56 | 0.520 |
Why?
| Intestines | 2 | 2016 | 345 | 0.510 |
Why?
| Delivery, Obstetric | 1 | 2016 | 135 | 0.490 |
Why?
| Informed Consent | 1 | 2016 | 174 | 0.460 |
Why?
| Endoscopy, Gastrointestinal | 2 | 2016 | 217 | 0.450 |
Why?
| Gastroenterology | 1 | 2016 | 174 | 0.430 |
Why?
| Gastrointestinal Hemorrhage | 2 | 2011 | 120 | 0.410 |
Why?
| Hyperbilirubinemia | 1 | 2012 | 11 | 0.400 |
Why?
| Muscle Cells | 1 | 2012 | 39 | 0.390 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2013 | 169 | 0.380 |
Why?
| Diabetes, Gestational | 2 | 2012 | 307 | 0.370 |
Why?
| Intra-Abdominal Fat | 1 | 2012 | 88 | 0.370 |
Why?
| Microbiota | 2 | 2016 | 720 | 0.370 |
Why?
| Esophageal Diseases | 1 | 2011 | 27 | 0.360 |
Why?
| Child | 12 | 2023 | 20721 | 0.350 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2012 | 508 | 0.350 |
Why?
| Adiposity | 2 | 2012 | 505 | 0.350 |
Why?
| Obesity | 2 | 2013 | 2860 | 0.340 |
Why?
| Infant | 7 | 2020 | 8913 | 0.320 |
Why?
| Lipid Metabolism | 1 | 2012 | 493 | 0.310 |
Why?
| Energy Metabolism | 1 | 2013 | 836 | 0.290 |
Why?
| Pediatrics | 1 | 2016 | 1061 | 0.290 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2013 | 551 | 0.280 |
Why?
| Hemorrhage | 1 | 2011 | 644 | 0.270 |
Why?
| Child, Preschool | 9 | 2020 | 10373 | 0.260 |
Why?
| Neoplasms | 1 | 2021 | 2465 | 0.260 |
Why?
| Liver | 1 | 2013 | 1827 | 0.240 |
Why?
| Humans | 25 | 2023 | 128524 | 0.230 |
Why?
| Esophageal Fistula | 2 | 2016 | 18 | 0.220 |
Why?
| Vascular Fistula | 2 | 2016 | 20 | 0.220 |
Why?
| Insulin Resistance | 1 | 2012 | 1166 | 0.220 |
Why?
| Mineral Oil | 1 | 2002 | 2 | 0.200 |
Why?
| Pneumonia, Aspiration | 1 | 2002 | 17 | 0.200 |
Why?
| Brain Abscess | 1 | 2021 | 10 | 0.190 |
Why?
| Adolescent | 6 | 2023 | 20213 | 0.190 |
Why?
| Retrospective Studies | 5 | 2023 | 14460 | 0.180 |
Why?
| Magnetic Resonance Imaging | 1 | 2012 | 3366 | 0.180 |
Why?
| Diagnostic Errors | 1 | 2021 | 160 | 0.180 |
Why?
| Federal Government | 1 | 2020 | 26 | 0.170 |
Why?
| Parents | 2 | 2021 | 1306 | 0.170 |
Why?
| State Government | 1 | 2020 | 43 | 0.170 |
Why?
| Female | 12 | 2020 | 68127 | 0.170 |
Why?
| Cardiovascular Diseases | 1 | 2012 | 2018 | 0.170 |
Why?
| Recurrence | 3 | 2023 | 1001 | 0.160 |
Why?
| Morbidity | 1 | 2020 | 302 | 0.160 |
Why?
| Legislation, Drug | 1 | 2020 | 81 | 0.160 |
Why?
| Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.160 |
Why?
| Magnets | 1 | 2018 | 19 | 0.150 |
Why?
| Treatment Outcome | 5 | 2023 | 10163 | 0.150 |
Why?
| Pregnancy | 4 | 2016 | 6297 | 0.150 |
Why?
| Male | 11 | 2021 | 62883 | 0.150 |
Why?
| Infant, Newborn | 3 | 2016 | 5687 | 0.150 |
Why?
| Medical Oncology | 1 | 2021 | 272 | 0.150 |
Why?
| Patient Safety | 1 | 2021 | 290 | 0.150 |
Why?
| Body Composition | 2 | 2012 | 656 | 0.150 |
Why?
| Nutritional Requirements | 1 | 2018 | 77 | 0.150 |
Why?
| Endocrine System | 1 | 2018 | 20 | 0.150 |
Why?
| Neuromuscular Junction | 1 | 2018 | 57 | 0.140 |
Why?
| Intestine, Small | 1 | 2018 | 141 | 0.140 |
Why?
| Stomach | 1 | 2017 | 109 | 0.140 |
Why?
| Intubation, Gastrointestinal | 1 | 2017 | 75 | 0.140 |
Why?
| Gastrostomy | 1 | 2017 | 112 | 0.130 |
Why?
| Nutritional Status | 1 | 2018 | 326 | 0.130 |
Why?
| Gastrointestinal Tract | 1 | 2018 | 182 | 0.120 |
Why?
| Down Syndrome | 1 | 2002 | 470 | 0.120 |
Why?
| Quality Improvement | 2 | 2020 | 1100 | 0.120 |
Why?
| Colonoscopy | 1 | 2017 | 233 | 0.120 |
Why?
| Rectum | 1 | 2016 | 169 | 0.120 |
Why?
| Disclosure | 1 | 2016 | 111 | 0.120 |
Why?
| Referral and Consultation | 1 | 2020 | 727 | 0.120 |
Why?
| Cohort Studies | 2 | 2017 | 5369 | 0.120 |
Why?
| Risk Factors | 3 | 2013 | 9727 | 0.120 |
Why?
| Vagina | 1 | 2016 | 175 | 0.110 |
Why?
| Attitude of Health Personnel | 1 | 2021 | 1090 | 0.110 |
Why?
| Disease Management | 1 | 2018 | 588 | 0.110 |
Why?
| Colorado | 2 | 2020 | 4392 | 0.110 |
Why?
| Sequence Analysis, DNA | 1 | 2016 | 773 | 0.110 |
Why?
| Young Adult | 2 | 2020 | 12320 | 0.100 |
Why?
| Cholestasis, Extrahepatic | 1 | 2012 | 4 | 0.100 |
Why?
| Hepatolenticular Degeneration | 1 | 2012 | 15 | 0.100 |
Why?
| Choledochal Cyst | 1 | 2012 | 16 | 0.100 |
Why?
| Hepatitis A | 1 | 2012 | 25 | 0.100 |
Why?
| Gallstones | 1 | 2012 | 31 | 0.100 |
Why?
| Biliary Tract Diseases | 1 | 2012 | 36 | 0.100 |
Why?
| Alagille Syndrome | 1 | 2012 | 33 | 0.100 |
Why?
| Aspartate Aminotransferases | 1 | 2012 | 85 | 0.100 |
Why?
| Bilirubin | 1 | 2012 | 92 | 0.100 |
Why?
| Intracellular Space | 1 | 2012 | 71 | 0.100 |
Why?
| Alanine Transaminase | 1 | 2012 | 150 | 0.090 |
Why?
| Skin | 1 | 2016 | 717 | 0.090 |
Why?
| Puberty | 1 | 2012 | 143 | 0.090 |
Why?
| Neonatal Screening | 1 | 2012 | 163 | 0.090 |
Why?
| Biliary Atresia | 1 | 2012 | 160 | 0.090 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2013 | 259 | 0.090 |
Why?
| Jejunal Diseases | 1 | 2009 | 7 | 0.080 |
Why?
| Trachea | 1 | 2011 | 221 | 0.080 |
Why?
| Capsule Endoscopy | 1 | 2009 | 18 | 0.080 |
Why?
| Liver Diseases | 1 | 2012 | 285 | 0.080 |
Why?
| Epigenesis, Genetic | 1 | 2013 | 616 | 0.080 |
Why?
| Decision Making | 1 | 2016 | 850 | 0.080 |
Why?
| Autoimmune Diseases | 1 | 2012 | 423 | 0.080 |
Why?
| Aorta | 1 | 2011 | 407 | 0.080 |
Why?
| Metformin | 1 | 2012 | 311 | 0.070 |
Why?
| Diagnosis, Differential | 1 | 2012 | 1416 | 0.070 |
Why?
| Phenotype | 1 | 2013 | 3050 | 0.060 |
Why?
| Genetic Predisposition to Disease | 1 | 2013 | 2266 | 0.060 |
Why?
| Reproducibility of Results | 1 | 2012 | 3023 | 0.060 |
Why?
| Adult | 3 | 2023 | 35315 | 0.060 |
Why?
| Age Factors | 1 | 2012 | 3117 | 0.060 |
Why?
| Prospective Studies | 1 | 2016 | 7043 | 0.060 |
Why?
| Practice Guidelines as Topic | 1 | 2011 | 1490 | 0.050 |
Why?
| Headache Disorders, Secondary | 1 | 2021 | 3 | 0.050 |
Why?
| Bronchoalveolar Lavage | 1 | 2002 | 89 | 0.050 |
Why?
| Tomography, X-Ray Computed | 2 | 2021 | 2521 | 0.050 |
Why?
| Neurologic Examination | 1 | 2021 | 114 | 0.050 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2001 | 48 | 0.050 |
Why?
| Reoviridae | 1 | 2001 | 37 | 0.050 |
Why?
| Constipation | 1 | 2002 | 89 | 0.050 |
Why?
| Endopeptidases | 1 | 2001 | 83 | 0.040 |
Why?
| Fatal Outcome | 1 | 2021 | 301 | 0.040 |
Why?
| X Chromosome | 1 | 2000 | 51 | 0.040 |
Why?
| Biomarkers | 1 | 2012 | 3881 | 0.040 |
Why?
| Prednisone | 1 | 2021 | 236 | 0.040 |
Why?
| Family Health | 1 | 2021 | 194 | 0.040 |
Why?
| Capsid | 1 | 2001 | 91 | 0.040 |
Why?
| Agammaglobulinemia | 1 | 2000 | 33 | 0.040 |
Why?
| Leucine | 1 | 2001 | 108 | 0.040 |
Why?
| Sucralfate | 1 | 2020 | 3 | 0.040 |
Why?
| Migraine Disorders | 1 | 2021 | 85 | 0.040 |
Why?
| Capsid Proteins | 1 | 2001 | 91 | 0.040 |
Why?
| Deglutition | 1 | 2020 | 67 | 0.040 |
Why?
| Arthritis, Infectious | 1 | 2000 | 59 | 0.040 |
Why?
| Critical Pathways | 1 | 2020 | 80 | 0.040 |
Why?
| Pneumococcal Infections | 1 | 2000 | 110 | 0.040 |
Why?
| Information Dissemination | 1 | 2020 | 204 | 0.040 |
Why?
| Needs Assessment | 1 | 2020 | 360 | 0.040 |
Why?
| Interprofessional Relations | 1 | 2020 | 270 | 0.040 |
Why?
| Nutrition Therapy | 1 | 2018 | 31 | 0.040 |
Why?
| RNA-Binding Proteins | 1 | 2001 | 379 | 0.040 |
Why?
| Eating | 1 | 2020 | 365 | 0.040 |
Why?
| Glucocorticoids | 1 | 2021 | 575 | 0.030 |
Why?
| Program Evaluation | 1 | 2020 | 874 | 0.030 |
Why?
| Time-to-Treatment | 1 | 2016 | 180 | 0.030 |
Why?
| Animals | 2 | 2013 | 34501 | 0.030 |
Why?
| Pandemics | 1 | 2020 | 1487 | 0.020 |
Why?
| Time Factors | 1 | 2002 | 6503 | 0.020 |
Why?
| Patient Care Team | 1 | 2016 | 600 | 0.020 |
Why?
| Prednisolone | 1 | 2009 | 82 | 0.020 |
Why?
| Algorithms | 1 | 2016 | 1616 | 0.020 |
Why?
| Intestinal Mucosa | 1 | 2009 | 575 | 0.010 |
Why?
| Cathepsin L | 1 | 2001 | 9 | 0.010 |
Why?
| Cathepsin D | 1 | 2001 | 17 | 0.010 |
Why?
| Cathepsins | 1 | 2001 | 24 | 0.010 |
Why?
| Cysteine Endopeptidases | 1 | 2001 | 67 | 0.010 |
Why?
| Virus Assembly | 1 | 2001 | 79 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2009 | 4898 | 0.010 |
Why?
| Genetic Linkage | 1 | 2000 | 299 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 2001 | 530 | 0.010 |
Why?
| Risk Assessment | 1 | 2009 | 3256 | 0.010 |
Why?
| Streptococcus pneumoniae | 1 | 2000 | 159 | 0.010 |
Why?
| Knee Joint | 1 | 2000 | 366 | 0.010 |
Why?
| Adaptation, Physiological | 1 | 2001 | 514 | 0.010 |
Why?
| Mutation | 1 | 2001 | 3692 | 0.010 |
Why?
| Mice | 1 | 2001 | 16579 | 0.000 |
Why?
|
|
Brumbaugh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|